Trial Profile
Efficacy of rosuvastatin versus atorvastatin in patients with non-intervened intermediate coronary stenosis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2011
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Coronary arteriosclerosis
- Focus Therapeutic Use
- 17 Jan 2011 New trial record